Inventor · disambiguated record
Lisa Mckerracher
Also filed as: MCKERRACHER LISA
19 granted patents·14 pending applications·247 citations·filing 2000–2024
94Inventor score
Files withBIOAXONE BIOSCIENCES INC17BIOAXONE THERAPEUTIQUE INC5MCKERRACHER LISA5LASKO DANA2UNIV MONTREAL2
Top patents by PatentIndex Score
33 records- 0193US10106525B2Rho kinase inhibitor BA-1049 (R) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2017·Granted Oct 23, 2018·11 cites·3 claims
- 0293US7572913B24-substituted piperidine derivativesBIOAXONE THERAPEUTIQUE INC·Filed 2005·Granted Aug 11, 2009·129 cites·19 claims
- 0390US10149856B2Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2017·Granted Dec 11, 2018·6 cites·6 claims
- 0490US6855688B2ADP-ribosyl transferase fusion proteins, pharmaceutical compositions, and methods of useBIOAXONE THERAPEUTIQUE INC·Filed 2002·Granted Feb 15, 2005·42 cites·25 claims
- 0588US10526313B2Rho kinase inhibitor BA-1049 (R) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2018·Granted Jan 7, 2020·3 cites·2 claims
- 0686US7141428B2Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereofMCKERRACHER LISA·Filed 2000·Granted Nov 28, 2006·20 cites·9 claims
- 0785US12384759B2Rho kinase inhibitor ba-1049 (r) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2023·Granted Aug 12, 2025·0 cites·18 claims
- 0885US9687483B2Treatment of cerebral cavernous malformations and cerebral aneurysms with Rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2016·Granted Jun 27, 2017·7 cites·10 claims
- 0981US7910554B2Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositionsBIOAXONE THERAPEUTIQUE INC·Filed 2008·Granted Mar 22, 2011·4 cites·20 claims
- 1079US10537567B2Kinase inhibitors for treatment of diseaseBIOAXONE BIOSCIENCES INC·Filed 2018·Granted Jan 21, 2020·1 cites·19 claims
- 1178US7795218B2ADP-ribosyl transferase fusion variant proteinsBIOAXONE THERAPEUTIQUE INC·Filed 2007·Granted Sep 14, 2010·8 cites·29 claims
- 1278US2024299409A1Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1373US7169783B2(+)-Trans-4-(1-aminoethyl)-1-(4-pyridycarbamoyl)-cyclohexane and method for promoting neural growth in the central nervous system and in a patient at a site of neuronal lesionUNIV MONTREAL·Filed 2001·Granted Jan 30, 2007·14 cites·8 claims
- 1471US11814361B2Rho kinase inhibitor BA-1049 (R) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2021·Granted Nov 14, 2023·0 cites·14 claims
- 1570US10857157B2Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2018·Granted Dec 8, 2020·0 cites·14 claims
- 1669US2009136573A1Methods for Making and Delivering Rho-Antagonist Tissue Adhesive Formulations to the Injured Mammalian Central and Peripheral Nervous Systems and uses ThereofMCKERRACHER LISA·Filed 2008·Application pending·0 cites
- 1769US2009285833A1Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreadingBIOAXONE THERAPEUTIQUE INC·Filed 2009·Application pending·0 cites
- 1868US11701366B2Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2020·Granted Jul 18, 2023·0 cites·7 claims
- 1967US2009142325A1Compositions and methods for treating tumour spreadingLASKO DANA·Filed 2008·Application pending·0 cites
- 2066US2008020000A1Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreadingBIOAXONE THERAPEUTIQUE·Filed 2004·Application pending·0 cites
- 2165US11198680B2Rho kinase inhibitor BA-1049 (R) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2020·Granted Dec 14, 2021·0 cites·2 claims
- 2265US7491692B2Methods for making and delivering Rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereofMCKERRACHER LISA·Filed 2003·Granted Feb 17, 2009·2 cites·12 claims
- 2362US2023399311A1Polymorphs of substituted isoquinoline-based rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2461US2022127617A1TREATMENT OF CNS INJURY WITH RNAi THERAPEUTICSBIOAXONE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2558US2006134140A1Compositions and methods for treating tumor spreadingLASKO DANA·Filed 2004·Application pending·0 cites
- 2657US2022265765A1C3 fusion protein and methods of making and using thereofBIOAXONE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2753US11324802B2C3 fusion protein and methods of making and using thereofBIOAXONE BIOSCIENCES INC·Filed 2018·Granted May 10, 2022·0 cites·9 claims
- 2851US2015297643A1Inhibition of rho and or rock and cell transplantationBIOAXONE BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 2948US11098308B2Treatment of CNS injury with RNAi therapeuticsBIOAXONE BIOSCIENCES INC·Filed 2017·Granted Aug 24, 2021·0 cites·16 claims
- 3047US2007128585A1(+)-trans-4-(1-aminoethyl)-1-(4-pyridycarbamoyl)-cyclohexane and method for promoting neural growth in the central nervous system and in a patient at a site of neuronal lesionUNIV MONTREAL·Filed 2006·Application pending·0 cites
- 3141US2004138272A11,4-Substituted cyclohexane derivativesFiled 2003·Application pending·0 cites
- 3240US2008233098A1RHO Family Antagonists and Their Use to Block Inhibition of Neurite OutgrowthMCKERRACHER LISA·Filed 2007·Application pending·0 cites
- 3336US2007270340A1ADP-ribosyl transferase fusion variant proteinsMCKERRACHER LISA·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lisa Mckerracher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →